Codiak BioSciences, based on research at the universities of Gothenburg and Texas, hoped to raise $86m in an initial public offering but has now withdrawn those plans.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The China Electronics and Shulan Health-backed medical data processing software provider collected $36.3m in a Tencent-led round that included Sinopharm.

Itochu Technology Ventures, Dai-ichi Life, Mizuho Capital and Mori Trust have contributed to a $20m round that increased the medical access app developer’s total funding to nearly $39m.

PureTech Health spinoff Karuna Therapeutics has upscaled its IPO to nearly $103m, after its shares rose by more than 50% in its first days of trading.

Mindfulness app developer Calm has added $27m to its series B round, after receiving an initial $88m tranche from investors including CAA five months ago.

Codiak Biosciences has withdrawn its proposed offering citing unfavourable market conditions, delaying an exit for investors including Alexandria Real Estate Equities.

Vaxess Technologies has received the final tranche of its $8.2m series A round led by MIT-affiliated incubator and venture capital fund The Engine.

Small molecule therapeutic developer Morphic, based on research at Harvard Medical School, has boosted its initial public offering from $90m to nearly $104m.

The corporate-backed small molecule therapeutic developer has boosted its initial public offering from $90m to nearly $104m.